Secondary Prevention of Cardiovascular Disease in the Elderly Trial

NCT02596126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2499

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Cardiovascular Disease

Interventions

DRUG: Cardiovascular Polypill
DRUG: Treatment Prevention for Secondary CV

Sponsor

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]